Geneva, April 28 -- International Clinical Trials Registry received information related to the study (KCT0011854) titled 'A study comparing the safety and efficacy of switching treatment to Vemlino tablets or Vemlidy tablets in patients with chronic hepatitis B who are receiving tenofovir disoproxil fumarate (TDF)' on April 15.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Single, Blinding Target : Investigator, Allocation : RCT
Primary Sponsor: Samil Pharm
Condition:
Certain infectious and parasitic diseases
Intervention:
Drug : In patients with chronic hepatitis B receiving tenofovir disoproxil fumarate (TDF), treatment is switched to Vemlino tablet...